When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DFFN - Ligand Acquisitions And Other News: The Good Bad And Ugly Of Biopharma
Diffusion Pharmaceuticals Inc.
Ligand inks deal to acquire Taurus and xCella Biosciences
Ligand Pharmaceuticals Inc. (LGND) reported that it has inked a deal to acquire two companies, xCella Biosciences Inc. and Taurus Biosciences. Both these companies are privately held and are expected to boost Ligand’s OmniAb® technology platform. The company also plans to invest in a new company led by the founder of Taurus Biosciences.
Under the terms of the deals, Ligand will pay $7 million in cash to xCella for the acquisition. xCella will also be entitled to potential earnouts. Taurus Biosciences will be paid